Personalis, Inc. reported second-quarter 2026 results showing revenue of $22.36M, up 30% from $17.2M a year earlier, while the company recorded a net loss of $31.68M and diluted loss per share of $(0.30), both wider than the prior-year quarter.Financial HighlightsBusiness HighlightsOriginal SEC Fil…
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.The proposed transactions may contain terms that could limit superior competing offers.Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We…
Tempus AI NASDAQ:TEM, a Chicago-based healthcare technology company using artificial intelligence for tailored disease prevention and treatment, has agreed to acquire Personalis NASDAQ:PSNL, a California-based cancer-testing company, in a transaction giving Personalis an equity valuation of $1.7 bi…
Shares of Tempus AI Inc. (TEM) fell more than 9% on Monday, while Personalis Inc. (PSNL) dropped nearly 15%, after Tempus announced a definitive agreement to acquire the precision oncology company in a deal valued at about $1.5 billion.While the market reacted negatively, Morgan Stanley said the tr…
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Personalis, Inc. (NASDAQ: PSNL) to Tempus AI, Inc. for $16.25 per share of common stock. The consideration is reported to be structured as a 100% stock transaction, with Tempus having the option to elect payment in cash at…
Shares of Personalis (PSNL) rose 5% after-hours on Thursday following rumors that the precision oncology company is exploring strategic options, including a potential sale, after receiving takeover interest from Merck & Co. (MRK) and at least two other parties.Personalis has hired investment banks…
Explore more price target data and ratings for Personalis, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Personalis, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information…
